Always report any adverse effects that may occur after vaccination against Covid-19. A need reiterated by the International Coalition of Medicines Regulatory Authorities (Icmra), in a joint appeal launched together with the World Health Organization (WHO) to strengthen confidence in pandemic coronavirus vaccines.
“ICMRA and WHO – informs the European Medicines Agency EMA, part of ICMRA – urge health professionals not only to diligently report the adverse events they observe in their patients, but also to encourage vaccinated people to immediately report any side effects that could occur. This helps the regulatory authorities to evaluate any possible link with vaccines – specifies the EMA – and to ensure that these products are used in the safest way “.
Covid vaccines have passed a rigorous evaluation for efficacy and safety and are continuously monitored. And “commitment” is needed to “strengthen people’s trust” in this, is the message that the European Medicines Agency EMA sends together with the regulatory bodies of the world and the WHO. Theirs is both an appeal and a reassurance. The mission, they explain in the joint statement, must be: “To help healthcare professionals increase trust in Covid vaccines and answer patients’ questions about the development, regulatory review and safety monitoring of these vaccines”.
The last few months, notes Emer Cooke, executive director of EMA and president of Icmra, “have really made us understand the importance of trust” in these shield products. “As mass vaccination campaigns continue, ICMRA and WHO reaffirm their commitment to support healthcare professionals and reassure the public that regulatory processes for vaccine authorization and monitoring of their safety are robust. and guided by patient needs, ”says Cooke.
The bodies emphasize that these products undergo extensive scientific evaluation to determine their safety, efficacy and quality. They also explain that there are measures in place to allow regulators to collect emerging vaccine safety data from a wide range of sources, and to take swift regulatory action to protect public health when needed.